Jeisys Medical Inc.

A287410

KR7287410005

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
9,450 ^KRW	+0.85%		-21.38%	-9.91%

Apr. 11	AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan	CI
Apr. 04	AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc.	CI

Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million.

November 13, 2023

The company closed its plan on November 14, 2023.

Latest news about Jeisys Medical Inc.

AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan	Apr. 11	CI
AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc.	Apr. 03	CI
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.	Nov. 20	CI
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.	Nov. 20	CI
Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million.	Nov. 13	CI
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China	Nov. 09	MT
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.	23-08-17	CI
Jeisys Medical Inc. announces an Equity Buyback.	23-05-15	CI
Jeisys Medical Inc. authorizes a Buyback Plan.	23-05-14	CI
Jeisys Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Cynosure KK Enters into Distribution Partnership with Jeisys Medical KK in Japan	22-03-18	CI
Jeisys Medical Inc.(KOSDAQ:A287410) added to S&P Global BMI Index	21-09-20	CI
SACCI Bio Co., Ltd. announced that it expects to receive KRW 2.85 billion in funding from Jeisys Medical Inc.	21-07-12	CI
Jeisys Medical Inc. completed the acquisition of Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others in a reverse merger transaction.	21-03-17	CI
Jeisys Medical Inc. signed a contract to acquire Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others for approximately KRW 300 billion in a reverse merger transaction.	20-09-20	CI
Jeisys Medical Inc. announced that it has received KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners Co., Ltd., LSK Investment	19-06-23	CI
Jeisys Medical Inc. announced that it expects to receive KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners, LSK Investment	19-05-23	CI

Jeisys Medical Inc, formerly Yuanta 3 Special Purpose Acquisition Co Ltd, a Korea-based company principally engaged in the manufacturing and distribution of medical devices. The Company manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jeisys Medical Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9,450 KRW

Average target price

14,038 KRW

Spread / Average Target

+48.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
JEISYS MEDICAL INC.	-9.91%	518M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology